[Cardiac and vascular malformations]

S Ley1, J Ley-Zaporozhan

  • 1Abteilung für Diagnostische und Interventionelle Radiologie, Chirurgische Klinik Dr. Rinecker, Am Isarkanal 30, 81379, München, Deutschland, ley@gmx.net.

Der Radiologe
|June 26, 2015
PubMed

Insights

This review covers common congenital heart defects, from subtle variations to severe conditions requiring immediate intervention. It highlights echocardiography as the primary diagnostic tool, with CT and MRI used less frequently for complex cases.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Pediatric Cardiology

Context:

  • Congenital heart malformations exhibit significant variability, ranging from asymptomatic incidental findings to critical conditions requiring neonatal surgical intervention.
  • Echocardiography is the primary diagnostic imaging modality for characterizing cardiac and vascular malformations.
  • Advanced imaging techniques like CT and MRI are reserved for complex cases, presenting challenges due to small anatomical structures and physiological parameters in neonates.

Purpose:

  • To review the most frequent vascular, cardiac, and complex cardiovascular malformations.
  • To discuss diagnostic imaging strategies for congenital heart disease.
  • To provide an overview of malformations irrespective of the initial diagnostic imaging modality.

Summary:

  • Congenital heart and great vessel malformations vary widely, with some detected incidentally (e.g., persistent left superior vena cava) and others necessitating prompt surgical treatment post-birth.
  • Echocardiography remains the gold standard for diagnosing and assessing these malformations, offering detailed morphological and functional insights.
  • While CT and MRI are valuable for specific complex cases, challenges in imaging neonates due to size and physiological rates exist; this review encompasses malformations regardless of the primary imaging modality used.

Impact:

  • Enhances understanding of the spectrum of congenital cardiovascular malformations.
  • Informs diagnostic imaging strategies for pediatric cardiology.
  • Provides a comprehensive resource for clinicians managing congenital heart disease.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.6K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.9K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
835
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.8K
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
15.2K